These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31442656)

  • 21. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis.
    Lorente L; Martín MM; Varo N; Borreguero-León JM; Solé-Violán J; Blanquer J; Labarta L; Díaz C; Jiménez A; Pastor E; Belmonte F; Orbe J; Rodríguez JA; Gómez-Melini E; Ferrer-Agüero JM; Ferreres J; Llimiñana MC; Páramo JA
    Crit Care; 2011 Mar; 15(2):R97. PubMed ID: 21406105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage.
    Chen XD; Sun J; Lu C; Ba HJ; Chen MH; Lin JH; Cai JY
    Thromb Res; 2015 Jul; 136(1):24-9. PubMed ID: 25944664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    Med Intensiva (Engl Ed); 2021 Apr; ():. PubMed ID: 33926751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 10-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (mMCAI).
    Lammy S; Al-Romhain B; Osborne L; St George EJ
    World Neurosurg; 2016 Dec; 96():383-389. PubMed ID: 27639522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between total antioxidant capacity and mortality in ischemic stroke patients.
    Lorente L; Martín MM; Pérez-Cejas A; Abreu-González P; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A
    Ann Intensive Care; 2016 Dec; 6(1):39. PubMed ID: 27107565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Single-Center Analysis.
    Kilic M; Ertem DH; Ozdemir B
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30704138
    [No Abstract]   [Full Text] [Related]  

  • 27. Poor Collateral Circulation Assessed by Multiphase Computed Tomographic Angiography Predicts Malignant Middle Cerebral Artery Evolution After Reperfusion Therapies.
    Flores A; Rubiera M; Ribó M; Pagola J; Rodriguez-Luna D; Muchada M; Boned S; Seró L; Sanjuan E; Meler P; Carcámo D; Santamarina E; Tomassello A; Lemus M; Coscojuela P; Molina CA
    Stroke; 2015 Nov; 46(11):3149-53. PubMed ID: 26419969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Mortality of Brain Infarction Patients and Red Blood Cell Distribution Width.
    Lorente L; Martín MM; Abreu-González P; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2020 Mar; 10(4):. PubMed ID: 32224967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
    Pusuroglu H; Akgul O; Erturk M; Uyarel H; Bulut U; Akkaya E; Buturak A; Surgit O; Fuat A; Cetin M; Yldrm A
    Coron Artery Dis; 2014 Nov; 25(7):558-64. PubMed ID: 25004238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between Intravoxel Incoherent Motion Magnetic Resonance Imaging Derived Metrics and Serum Soluble CD40 Ligand Level in an Embolic Canine Stroke Model.
    Xu XQ; Wu CJ; Lu SS; Gao QQ; Zu QQ; Liu XL; Shi HB; Liu S
    Korean J Radiol; 2017; 18(5):835-843. PubMed ID: 28860901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Tascanov MB; Tanriverdi Z; Gungoren F; Besli F; Erkus ME; Gonel A; Koyuncu I; Demirbag R
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31311177
    [No Abstract]   [Full Text] [Related]  

  • 32. Decompressive hemicraniectomy in pediatric patients with malignant middle cerebral artery infarction: case series and review of the literature.
    Shah S; Murthy SB; Whitehead WE; Jea A; Nassif LM
    World Neurosurg; 2013; 80(1-2):126-33. PubMed ID: 23791748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality prediction of ischemic stroke patients without thrombectomy by blood total antioxidant capacity.
    Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Abreu-González P; Sabatel R; Ramos-Gómez L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    J Integr Neurosci; 2020 Sep; 19(3):501-506. PubMed ID: 33070530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Thromb Res; 2007; 121(3):293-9. PubMed ID: 17521712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
    Rondina MT; Lappé JM; Carlquist JF; Muhlestein JB; Kolek MJ; Horne BD; Pearson RR; Anderson JL
    Cardiology; 2008; 109(3):196-201. PubMed ID: 17726321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization.
    Gremmel T; Frelinger AL; Michelson AD
    PLoS One; 2015; 10(8):e0134599. PubMed ID: 26237513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation.
    Ivandic BT; Spanuth E; Haase D; Lestin HG; Katus HA
    Clin Chem; 2007 Jul; 53(7):1231-4. PubMed ID: 17495016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of plasma soluble CD40 ligand levels in patients with nasopharyngeal carcinoma.
    Zhao P; Fang WJ; Chai L; Ruan J; Zheng Y; Jiang WQ; Lin S; Zhou SH; Zhang ZL
    Clin Chim Acta; 2015 Jul; 447():66-70. PubMed ID: 26032866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.